Dalian BIO-CHEM Company Limited (603360.SS)
CNY 28.36
(1.29%)
CNY 28.36
(1.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 385.92 Million CNY | -16.4% |
| 2022 | 461.62 Million CNY | 52.49% |
| 2021 | 302.72 Million CNY | 16.11% |
| 2020 | 260.71 Million CNY | -29.07% |
| 2019 | 367.54 Million CNY | 113.54% |
| 2018 | 172.11 Million CNY | 36.1% |
| 2017 | 126.46 Million CNY | 16.73% |
| 2016 | 108.33 Million CNY | 75.72% |
| 2015 | 61.65 Million CNY | -7.58% |
| 2014 | 66.7 Million CNY | 27.06% |
| 2013 | 52.5 Million CNY | 11.92% |
| 2012 | 46.9 Million CNY | 1.5% |
| 2011 | 46.21 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 74.38 Million CNY | -33.85% |
| 2024 Q3 | 97.68 Million CNY | 31.32% |
| 2024 Q1 | 112.46 Million CNY | 91.99% |
| 2023 Q2 | 136.49 Million CNY | 63.49% |
| 2023 Q3 | 107.35 Million CNY | -21.35% |
| 2023 Q4 | 58.57 Million CNY | -45.44% |
| 2023 FY | 385.92 Million CNY | -16.4% |
| 2023 Q1 | 83.48 Million CNY | 38.74% |
| 2022 FY | 461.62 Million CNY | 52.49% |
| 2022 Q3 | 133.79 Million CNY | -11.1% |
| 2022 Q2 | 150.49 Million CNY | 28.45% |
| 2022 Q1 | 117.16 Million CNY | 3.44% |
| 2022 Q4 | 60.17 Million CNY | -55.02% |
| 2021 FY | 302.72 Million CNY | 16.11% |
| 2021 Q3 | 44.59 Million CNY | -46.79% |
| 2021 Q4 | 113.26 Million CNY | 153.96% |
| 2021 Q1 | 61.05 Million CNY | 10.13% |
| 2021 Q2 | 83.8 Million CNY | 37.27% |
| 2020 Q3 | 54.1 Million CNY | 5.31% |
| 2020 Q1 | 99.79 Million CNY | -0.11% |
| 2020 FY | 260.71 Million CNY | -29.07% |
| 2020 Q4 | 55.43 Million CNY | 2.46% |
| 2020 Q2 | 51.37 Million CNY | -48.52% |
| 2019 Q4 | 99.9 Million CNY | -26.04% |
| 2019 Q1 | 38.3 Million CNY | -10.8% |
| 2019 Q2 | 94.24 Million CNY | 146.07% |
| 2019 Q3 | 135.08 Million CNY | 43.33% |
| 2019 FY | 367.54 Million CNY | 113.54% |
| 2018 Q4 | 42.93 Million CNY | -19.28% |
| 2018 Q3 | 53.19 Million CNY | 23.93% |
| 2018 Q2 | 42.92 Million CNY | 29.79% |
| 2018 Q1 | 33.06 Million CNY | -8.41% |
| 2018 FY | 172.11 Million CNY | 36.1% |
| 2017 Q2 | 28.82 Million CNY | -8.04% |
| 2017 Q4 | 36.1 Million CNY | 19.64% |
| 2017 FY | 126.46 Million CNY | 16.73% |
| 2017 Q1 | 31.35 Million CNY | 21.35% |
| 2017 Q3 | 30.17 Million CNY | 4.68% |
| 2016 Q4 | 25.83 Million CNY | -22.93% |
| 2016 Q1 | 21.83 Million CNY | 188.23% |
| 2016 Q2 | 27.14 Million CNY | 24.3% |
| 2016 FY | 108.33 Million CNY | 75.72% |
| 2016 Q3 | 33.52 Million CNY | 23.5% |
| 2015 FY | 61.65 Million CNY | -7.58% |
| 2015 Q4 | 7.57 Million CNY | 0.0% |
| 2014 Q1 | 20.74 Million CNY | 0.0% |
| 2014 Q2 | 20.74 Million CNY | 0.0% |
| 2014 FY | 66.7 Million CNY | 27.06% |
| 2013 FY | 52.5 Million CNY | 11.92% |
| 2012 FY | 46.9 Million CNY | 1.5% |
| 2011 FY | 46.21 Million CNY | 0.0% |